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Background: Cationic polymers have been accepted as effective nonviral vectors for gene 
delivery with low immunogenicity unlike viral vectors. However, the lack of organ or cell speci-
ficity sometimes hampers their application and the modification of polymeric vectors has also 
shown successful improvements in achieving cell-specific targeting delivery and in promoting 
intracellular gene transfer efficiency.
Methods: A folic acid-conjugated stearic acid-grafted chitosan (FA-CS-SA) micelle,   synthesized 
by a 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide-coupling reaction, was designed for 
specific receptor-mediated gene delivery.
Results: Due to the cationic properties of chitosan, the micelles could compact the plasmid DNA 
(pDNA) to form micelle/pDNA complexes nanoparticles. The particle size and zeta potential of 
the FA-CS-SA/pDNA complexes with different N/P ratios were 100–200 nm and -20 to -10 mV , 
respectively. The DNase I protection assay indicated that the complexes can efficiently protect 
condensed DNA from enzymatic degradation by DNase I. A cytotoxicity study indicated that 
the micelles exhibited less toxicity in comparison with LipofectamineTM 2000. Using SKOV3 
and A549 as model tumor cells, the cellular uptake of micelles was investigated.
Conclusion: It was found that cellular uptake of FA-CS-SA in SKOV3 cells with higher folate 
receptor expression was faster than that in A549 cells with a short incubation time. Luciferase 
assay and green fluorescent protein detection were used to confirm that FA-CS-SA could be an 
effective gene vector. Transfection efficiency of the FA-CS-SA/pDNA complexes in SKOV3 cells 
was enhanced up to 2.3-fold compared with that of the CS-SA/pDNA complexes. However, 
there was no significant difference between the transfection efficiencies of the two complexes 
in A549 cells. Importantly, the transfection efficiency of FA-CS-SA/pDNA decreased with free 
FA pretreatment in SKOV3 cells. It was concluded that the increase in transfection efficiency of 
the FA-CS-SA/pDNA complexes was attributed to folate receptor-mediated endocytosis.
Keywords: stearic acid-grafted chitosan, folic acid, polymeric micelles, folate receptor  targeting, 
gene delivery
Introduction
Gene therapy is considered to be a powerful approach to the treatment of congenital 
and acquired diseases, by producing bioactive agents or stopping abnormal functioning 
of cells, such as genetic disorders or uncontrolled proliferation of cells. However, the 
lack of effective vectors is a major barrier to progress in human gene delivery.1 Virus 
vectors are very effective in terms of transfection efficiency, but their application in the 
human body is often frustrated by immunogenicity, potential infectivity, complicated 
production, and inflammation.2 The limitations of viral vectors have led to the evaluation 
and development of alternative vectors based on nonviral systems, such as liposomes3 International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1560
Du et al
and nanoparticles.4 Cationic nanoparticles have emerged as one 
of the most attractive carriers because of their ability to form 
complexes with negatively charged small interfering RNA 
(siRNA) and their high transfection efficiency.5 Chitosan has 
been considered to be a good gene carrier candidate, because 
it is known to be a biodegradable, biocompatible, low immu-
nogenicity, and nontoxic material.6,7 Chitosan, as a cationic 
natural polysaccharide, can be complexed with negatively 
charged DNA by ionic interactions and protect DNA against 
DNase degradation.8,9 However, the low transfection efficiency 
and low specificity of chitosan must be overcome for its use in 
gene delivery. In addition, chitosan is poorly soluble because 
its amino groups are only partially protonated at physiologi-
cal pH 7.4. Low molecular weight chitosan has been focused 
on for gene delivery systems because of its good solubility in 
physiological conditions, higher gene transfection, and more 
efficient enzymatic protection.10–12 Moreover, chitosan con-
tains reactive amino and hydroxyl groups, thus many chitosan 
derivatives can be obtained by chemically altering its proper-
ties under mild reaction conditions.13,14 One approach to the 
improvement of transfection efficiency involves conjugating 
hydrophobic units with the polysaccharide backbone through 
amino groups or hydroxyl groups.15
An ideal gene carrier system should efficiently accumulate 
in specific target tissues with minimal toxicity to nontarget 
tissues.16 In order to increase the transfection efficiency of poly-
mer/DNA complexes to tumor cells specifically, various target-
ing ligands, including antibodies, growth factors, peptides, and 
folate have been conjugated to several polymers.17–19 Folic acid 
(FA) has emerged as an optimal ligand for targeting the cell 
membrane and allows nanoparticle endocytosis via the folate 
receptor for higher transfection yields. At present, the folate 
receptor is a major focus in multiple experimental approaches 
to tumor-targeted therapy. The folate receptor is known to be 
overexpressed on many human cancer cell surfaces, such as the 
brain, kidney, lung, ovarian, and breast cancers, but is highly 
restricted in most normal tissues.20 When folate is covalently 
linked to a molecule via its carboxyl moiety, its affinity for its 
cell surface receptor (Kd about 10–9 M) remains essentially 
unaltered. Some novel polymers have been synthesized, like 
folate-polylysine21 and folate-polyethylenimine,22, 23 all of 
which specifically increase gene transfection efficiency in 
target cells compared with nontargeted polymers.
In our previous research, novel self-aggregated micelles 
were formed by an amphiphilic-grafted copolymer, ie, stearic 
acid-grafted chitosan copolymer (CS-SA). The micelles 
have a specific spatial structure with multiple hydrophobic 
domains near their surface, and thus achieve excellent inter-
nalization into cancer cells.24 They have been investigated 
in detail as a gene vector, but their transfection efficiency 
is not so well understood. Moreover, the cellular uptake of 
CS-SA/DNA complexes lacks specificity. Therefore, CS-SA 
copolymers were further modified with folic acid to increase 
gene transfection efficiency in target cells specifically, and 
then folate-conjugated CS-SA (FA-CS-SA) was synthesized, 
and its properties were investigated. A FA-CS-SA/pDNA 
complex was then prepared by ionic interaction, and physi-
cochemical characterization of the complex was carried out. 
Cellular uptake in vitro was evaluated in SKOV3 cells (a 
folate receptor-overexpressing cell line) and A549 cells (a 
folate receptor-deficient cell line). In addition, the in vitro 
transfection efficiency of FA-CS-SA/pDNA complexes in 
terms of green fluorescent protein detection and the luciferase 
assay was also examined in the two cell lines.
Materials and methods
Materials
Chitosan of low molecular weight (5.0 kDa) was obtained by 
enzymatic degradation (molecular weight 450.0 kDa, 95% 
deacetylated, Yuhuan Marine Biochemistry Co Ltd, Zhejiang, 
China).25 Stearic acid was obtained from Chemical Reagent 
Co Ltd (Shanghai, China). 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide (EDC), 2,4,6-trinitrobenzene sulfonic 
acid (TNBS), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) were purchased from Sigma 
(St Louis, MO). Fetal bovine serum was purchased from 
Sijiqing Biologic Co Ltd (Zhejiang, China). Folic acid and 
fluorescein isothiocyanate (FITC) came from Sigma (St 
Louis, MO), and LipofectamineTM 2000 was supplied by 
Invitrogen Corporation (Carlsbad, CA). DNase I, Dulbecco’s 
Modified Eagle’s Medium, and trypsin-ethylenediamine 
tetra-acetic acid were purchased from Gibco BRL (Gaith-
ersberg, MD). Green fluorescent protein plasmid DNA 
(EGFP-C1) was donated by the first Affiliated Hospital of 
College of Medicine, Zhejiang University, Hangzhou, China. 
PGL-3, as the luciferase reporter gene, was kindly provided 
by the Institute of Life Science, Zhejiang University, Hang-
zhou, China. A luciferase assay kit and bicinchoninic acid 
protein assay kit were obtained from Beyotime Institute of 
Biotechnology, China. All other chemicals were of analytical 
grade and used without further purification.
synthesis of cs-sA
CS-SA was synthesized via reaction of the carboxyl groups 
of SA with the amine groups of CS, catalyzed by EDC. 
In brief, 1.0 g of CS was dissolved in 120 mL of distilled 
water. SA 0.4 g with EDC (SA:EDC 1:10, mol:mol) was 
then dissolved in 80 mL of ethanol by sonication, followed International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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by stirring in a water bath at 60°C for 1 hour. The mixture 
was added to the CS solution and the reaction was con-
ducted with 400 rpm for 5 hours at 80°C in a water bath. 
After the reaction mixture was cooled to room temperature, 
the synthesized product was dialyzed using a dialysis 
membrane (molecular weight cutoff 3.5 kDa, Spectrum 
Laboratories, Laguna Hills, CA) against distilled water 
for 48 hours in order to remove byproducts, followed by 
freeze drying. The lyophilized product was washed twice 
with ethanol to remove any unreacted SA.
synthesis of FA-cs-sA copolymer
The free amino groups of CS-SA were conjugated with 
the carboxylic groups of FA in the presence of EDC. The 
carboxyl groups of FA were activated by EDC. Briefly, FA 
dissolved in dimethyl sulfoxide was reacted with 10 molar 
equivalents of EDC at room temperature for 1 hour under 
stirring. Thereafter, it was added to the CS-SA solution, and 
the resulting mixture was stirred at room temperature in the 
dark for 16 hours. The mixture was dialyzed against distilled 
water for 3 days and then lyophilized.
characterization of FA-cs-sA
The critical micelle concentration of FA-CS-SA in aque-
ous medium was determined by fluorescence measurement 
using pyrene as a probe.26 Briefly, 6 mg of pyrene was firstly 
dissolved in 50 mL of acetone as a pyrene stock solution. 
Before use, the pyrene stock solution was further diluted 
100-fold with acetone; 0.5 mL of pyrene solution with a 
concentration of 0.0012 mg/mL was transferred into test 
tubes, the acetone was then evaporated at 50°C, and 5 mL 
of FA-CS-SA solution at different concentrations varying 
from 1.0 × 10–3 to 1.0 mg/mL was added to the test tubes. 
The final concentration of pyrene was fixed at 6 × 10–7 M. 
The fluorescence emission spectrum of pyrene was obtained 
using a fluorometer (F-2500, Hitachi Corporation, Osaka, 
Japan). The slit openings were set at 10 nm (excitation) 
and 2.5 nm (emission), and the excitation wavelength was 
337 nm. The intensity ratio of the first highest energy bands 
(374 nm) to the third (385 nm) in the pyrene emission spectra 
was then calculated.
The degrees of amino substitution of FA-CS-SA were 
determined by the TNBS method.27 Then 0.3 mL of FA-
CS-SA solution at a concentration of 1 mg/mL was incu-
bated with 2 mL of 4% NaHCO3 and 2 mL of 0.1% TNBS 
at 37°C for 2 hours. The mixture was then added to 2 mL 
of HCl (2 mol/L) and measured at 344 nm by an ultraviolet 
spectrophotometer (TU-1800PC, Beijing Purkinje General 
Instrument Co Ltd, Beijing, China). The degrees of amino 
substitution for CS-SA were measured in a similar way to 
that described above. The FA to amino group molar ratio in 
the FA-CS-SA copolymer was estimated indirectly.
The size and zeta potential of the micelles with 1 mg/
mL of FA-CS-SA were measured by dynamic light scatter-
ing using a Zetasizer (3000 HS; Malvern Instruments Ltd, 
Worcester, UK). Each sample determination was done in 
triplicate.
Preparation of FA-cs-sA/pDNA  
nanoparticles
Briefly, FA-CS-SA was dissolved in deionized water at a con-
centration of 1 mg/mL. The solution was then filtered using 
a 0.22 µm Millipore filter. The plasmid DNA was diluted 
with phosphate-buffered saline to give a concentration of 
0.5 mg/mL. Nanoparticles were prepared by mixing pDNA 
with appropriate polymer solution at various charge ratios. 
The charge ratio (N/P) of FA-CS-SA/pDNA was expressed 
as the molar ratio of the primary amino group of FA-CS-SA 
to the phosphate groups of DNA. The complex was then vor-
texed for 30 seconds and incubated for 30 minutes at room 
temperature for complete complex formation.
Determination of particle size  
and zeta potential
Particle size and zeta potential of the FA-CS-SA/pDNA 
nanoparticles was determined by dynamic light scattering 
(Zetasizer 3000HS). Each sample determination was done 
in triplicate.
gel retardation assay
The DNA binding ability of FA-CS-SA was evaluated by aga-
rose gel electrophoresis. The FA-CS-SA/DNA nanoparticles 
containing 1.0 µg of DNA were prepared at different N/P 
ratios (0.1, 0.2, 0.4, 0.8, 1.6, 3.2, and 6.4, respectively), by 
varying the concentration of FA-CS-SA. The nanoparticles 
and the naked plasmid were loaded into individual wells 
with 1.0% agarose gel in Tris-acetate-ethylenediamine tetra-
acetic acid buffer. The samples were run on the gel at 100 
V for 40 minutes. Finally, the gel was stained with 0.5 mg/
mL ethidium bromide and photographed using an ultraviolet 
spectrophotometer (UV-1601; Shimadzu, Kyoto, Japan). As 
a control, the DNA binding ability of CS-SA was also evalu-
ated by the same process as described for FA-CS-SA.
DNase I protection assay
Protection and release of DNA in FA-CS-SA/pDNA nano-
particles were carried out by electrophoresis according to the 
method described by Park et al.28 Briefly, 4 µL of DNase I International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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(2 units) or phosphate-buffered saline in DNase/Mg2+ diges-
tion buffer (50 mM, Tris-Cl, pH 7.6 and 10 mM MgCl2) was 
added to 0.5 µg of naked plasmid DNA or 4 µL of nanoparticle 
solution and incubated at 37°C with shaking at 100 rpm for 
30 minutes. For DNase inactivation, all the samples were treated 
with 4 µL of ethylenediamine tetra-acetic acid (250 mM) for 
10 minutes, and 1% sodium dodecyl sulfate dissolved in 0.1 
M NaOH (pH 7.2) was then added to a final volume of 18 µL. 
The final samples were further incubated for 2 hours to allow 
complete dissociation of complexes, and electrophoresis was 
performed with 1% agarose gel in Tris-acetate-ethylenediamine 
tetra-acetic running buffer for 1 hour at 100 V .
cell culture
SKOV3 and A549 cells were maintained in Dulbecco’s 
  Modified Eagle’s Medium or RPMI 1640 media supple-
mented with 10% fetal bovine serum, penicillin 100 U/mL, 
streptomycin 100 U/mL. Both cell lines were cultured at 
37°C in a humidified 5% CO2 atmosphere.
cellular uptake studies
In order to investigate cellular uptake, FA-CS-SA copolymer 
was labeled with FITC via reaction of the amino groups of 
chitosan and the isothiocyanate groups of FITC. The molar 
ratio of FA-CS-SA to FITC was fixed at 2:1. The solution was 
then stirred for 12 hours with 400 rpm at room temperature in 
aphotic environment. The reaction product was dialyzed against 
distilled water using a dialysis membrane (molecular weight 
cutoff 3.5 kDa, Spectrum Laboratories, Laguna Hills, CA) for 
24 hours to remove the unreacted FITC. SKOV3 and A549 cells 
were seeded at 3 × 104 cells/well in a 24-well plate, and grown 
for 24 hours. After removing the growth medium, 1.0 mL RPMI 
1640 medium containing 100 µg FITC-labeled FA-CS-SA 
was added. The cells were further incubated for 1, 2, 3, 6, 12, 
and 24 hours, respectively. The cells were then washed twice 
with phosphate-buffered saline (pH 7.4) and directly viewed 
under a fluorescence microscope (Leica DM4000 B; Leica, 
Solms, Germany). The fluorescence images were obtained at 
20× magnification. As a control, FITC-labeled CS-SA was used 
to observe cellular uptake as described above.
In vitro cytotoxicity assay
The cytotoxicity of the copolymers was measured by 
MTT assay. SKOV3 and A549 cells were seeded at a den-
sity of 1 × 104 cells/well in 200 µL complete medium in 
96-well plates and incubated for 24 hours at 37°C. The 
growth medium was then removed and replaced with fresh 
medium containing copolymer (CS-SA or FA-CS-SA) or 
  Lipofectamine 2000. The cells were then incubated further 
for 48 hours. After incubation, 20 µL of MTT (5.0 mg/mL) 
was added and incubated for 4 hours under normal growing 
conditions. After the medium with the unreacted MTT was 
removed, 200 µL of dimethyl sulfoxide was added to each 
well. The well plates were shaken for 20 minutes and the 
absorbance of formazan product was measured at 570 nm 
in a microplate reader (Model 680; BioRad, Mountain View, 
CA). Cells without polymers were used as a control.
In vitro transfection studies
SKOV3 and A549 cells were seeded in 24-well plates at a 
density of 1 × 105 cells per well in 1 mL of complete medium 
and incubated for 24 hours prior to transfection. The media was 
then replaced with fresh growth medium in each well. pDNA 
was diluted with phosphate-buffered saline (pH 7.4) to 0.5 mg/
mL, and then added to an appropriate amount of the copolymer 
in the same buffer with an equal volume to obtain the desired 
N/P ratios. The complexes were mixed using a vortex mixer 
for 30 seconds and then allowed to stand for 30 minutes at 
room temperature. Complexes containing 2 µg EGFP plasmid 
were subsequently added to the wells and incubated with the 
cells initially for 6 hours. The medium was then replaced with 
1 mL of fresh complete medium, and the cells were incubated 
for an additional 24–72 hours at 37°C. As a positive control, 
transfection with Lipofectamine 2000/DNA complexes was 
performed according to the manufacturer’s protocol. Briefly, 
Lipofectamine 2000/DNA complexes were incubated with 
cells in 1 mL of serum-free medium for 6 hours, and further 
incubated with fresh complete medium for 24–72 hours at 
37°C. Naked DNA was used on the cell cultures and examined 
as described above. All transfection experiments were per-
formed in triplicate. The cells were transferred to an inverted 
fluorescence microscope (Leica DMI 4000B) for imaging.
To evaluate transfection efficiency, FA-CS-SA/DNA 
  complexes (2 µg pGL3 plasmid) were prepared for transfec-
tion into SKOV3 and A549 cells. The transfection procedure 
was carried out using methods similar to those described 
above. Transfection efficiency was detected by assay of 
luciferase activity. After incubation for 72 hours with the 
cells, the growth medium was removed, and the cells were 
lysed with cell lysate buffer (Beyotime) and shaken for 
30 minutes at room temperature. The luciferase assay was 
carried out according to the manufacturer’s instructions. Rela-
tive light units were measured using a luminometer (Turner 
Designs Luminometer Model TD-20/20, Promega), and 
the protein assay was performed using a bicinchoninic acid 
protein assay reagent kit (Beyotime). The final results were 
reported in terms of relative light units/mg cellular protein. 
All transfection experiments were performed in triplicate.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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FA competition studies
SKOV3 and A549 cells were cultured in the same condi-
tions as those used for the transfection tests. The cells were 
seeded in 24-well plates at 1 × 105 cells/well and incubated for 
24 hours. One hour before the transfection test, the medium 
was replaced with RPMI 1640 containing FA 5.0 mM. The 
cells were then treated with FA-CS-SA/pDNA complex 
containing 2 µg of plasmid DNA at predetermined N/P ratios 
for 6 hours at 37°C in 5% CO2. After an exchange of fresh 
medium, the cells were further incubated for 24–72 hours at 
37°C. Transfection efficiency was assessed using the same 
method as described for the luciferase assay.
Results and discussion
synthesis of FA-cs-sA
CS-SA was synthesized via reaction of the amino groups of 
CS with the carboxyl groups of SA in the presence of EDC. 
The degree of amino substitution in the prepared CS-SA 
was about 19.9%, as determined by the TNBS method. 
CS-SA micelles were easily prepared by dispersing CS-SA 
in distilled water under ultrasound, due to the inherent self-
aggregation of CS-FA in an aqueous environment. FA-CS-SA 
could be synthesized by chemically linking FA to CS-SA 
via the reaction of the carboxyl groups of FA and the amino 
groups on the CS-SA micelle surface, in the presence of EDC. 
The degree of amino substitution of FA-CS-SA was 25.2%, 
as determined by the TNBS methods. The molar ratio of folic 
acid/NH2 in FA-CS-SA copolymer was 5.3%.
characteristics of FA-cs-sA
The aggregation behavior of FA-CS-SA and CS-SA in 
aqueous media was measured by fluorometry using pyrene 
as a fluorescent probe. The critical micelle concentration 
refers to the threshold self-aggregation concentration of 
amphiphilic polymer. The I1/I3 ratio, ie, the first to third 
highest energy bands in the pyrene emission spectra 
(I1, em = 374 nm; I3, em = 385 nm) was used to determined 
the critical micelle concentration value of the polymer. 
As the concentration increased to form micelles, the total 
emission fluorescence intensity increased, especially the 
intensity of the third highest energy band. As a result, the 
fluorescence intensity ratio of I1/I3 decreased. Variation in 
the fluorescence intensity ratio of I1/I3 against the loga-
rithm of FA-CS-SA and CS-SA concentration is shown in 
Figure 1. The critical micelle concentration values of FA-
CS-SA and CS-SA in distilled water were determined to 
be about 105 µg/mL and 147 µg/mL, respectively, which 
showed that the modification of FA improved the ability of 
CS-SA to self-assemble in water.
The distributions of hydrodynamic diameter and zeta 
potential of FA-CS-SA micelles with 1 mg/mL of FA-CS-SA 
are shown in Figure 2. The average hydrodynamic diameter 
and zeta potential of the FA-CS-SA micelles was 51.1 nm 
and 13.7 ± 4.7 mV , respectively.
characteristics of FA-cs-sA/DNA 
nanoparticles
Due to its positive charge, the FA-CS-SA micelle was used to 
condense DNA, forming FA-CS-SA/DNA complex nanopar-
ticles. The FA-CS-SA/DNA complex nanoparticles with N/P 
ratios from 0.25 to 20 were prepared by mixing the appropri-
ate volume of FA-CS-SA micelle solution and DNA solution. 
The size and zeta potential of the nanoparticle complexes 
were measured using a dynamic light scattering technique. 
Figure 3 showed the Z-average diameter and zeta potential 
of FA-CS-SA/DNA complexes at various charge ratios. The 
size of the FA-CS-SA/DNA complexes increased as the N/P 
ratio increased from 0.25 to 1. When the N/P ratio was about 
1, precipitation occurred and the size increased to microlevels 
due to the charge neutrality. Again, on increasing the N/P 
ratio, the size was found to decrease below 200 nm. The 
zeta potential of the FA-CS-SA/DNA complexes   (Figure 3) 
showed that the zeta potential changed from negative to 
positive when the N/P ratio increased from 0.5 to 20. The 
complexes had the highest zeta potential when the N/P ratio 
was about 2. With increasing N/P ratios, the zeta potential 
was found to approach a plateau, with no significant variation 
in the zeta potential.
In order to determine the ability of FA-CS-SA to condense 
DNA, solutions of FA-CS-SA/DNA with different N/P ratios 
were electrophoresed on agarose gel containing ethidium 
bromide. Complete retardation of FA-CS-SA/DNA complexes 
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was observed at N/P ratios of 0.8 and onwards (Figure 4B). 
As a control, the migration of CS-SA/DNA complexes was 
performed when the N/P ratio was above 0.8 (Figure 4A). The 
results indicate that FA-CS-SA had a stronger ability than 
CS-SA to condense DNA into nanoparticles.
DNase I protection assay
Protection of plasmid DNA from nucleases is a primary 
requisite for efficient gene delivery in vivo and in vitro.29 As 
shown in Figure 5, dissociation of DNA from copolymers 
was achieved although some still remained as a complex. 
Unlike the naked plasmid DNA control, the copolymer 
protected DNA. When naked pDNA was treated with two 
units of DNase I, it was completely degraded without any 
smear (lane 2). After adding 1% sodium dodecyl sulfate, 
the pDNA could be released from the FA-CSO-SA/pDNA 
complexes (lane 3 and lane 4). The Figure shows that at the 
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same concentration of DNase I, the pDNA was protected 
from degradation by FA-CSO-SA micelles effectively when 
the N/P ratio was 2.
cellular uptake
It has been demonstrated that folate-mediated biomolecular 
uptake is roughly proportional to the folate receptor density 
on the target cell membrane. To investigate the targeting effi-
ciency of FA-CS-SA micelles, the cellular uptake of FA-CS-SA 
labeled with FITC was evaluated in SKOV3 cells and visualized 
using fluorescence microscopy (Figure 6A). After 0.5 hours 
of incubation, FITC-labeled FA-CS-SA was distributed in the 
SKOV3 cells, with green fluorescence throughout the entire 
cytoplasm. However, CS-SA was detected only as spot-like 
fluorescence. With a longer   incubation time, fluorescence was 
enhanced, with a significant difference in fluorescence intensity 
between FA-CS-SA and CS-SA in the SKOV3 cells.
When the CS-SA copolymers were conjugated with FA, 
cellular uptake was mainly mediated by FA during a short 
incubation time, which indicated that shortening the incuba-
tion time was helpful to see the difference in cellular uptake 
between the two micelles. After 8 hours of incubation, with 
further enhanced fluorescence of CS-SA, the difference 
12 34
Figure  5  Protection  and  release  assay  of  DNA.  Lane  1  represents  naked 
DNA(pegFP-c1);  lane  2  represents  naked  DNA  treated  with  DNase  I;  lane  3 
represents  folic  acid-conjugated  stearic  acid-grafted  chitosan  copolymer/DNA 
complex;  lane  4  represents  folic  acid-conjugated  stearic  acid-grafted  chitosan 
copolymer/DNA complex treated with DNase I.
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Figure 6 Fluorescence images of (A) sKOV3 cells and (B) A549 cells incubated with FITc-labeled stearic acid-grafted chitosan copolymer and folic acid-conjugated stearic 
acid-grafted chitosan copolymer for 0.5, 3.0, and 8.0 hours.
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between the two micelles disappeared. This is because of 
the increasing concentration of micelle complexes in the 
cells, with the internalization ability attributed to the cellular 
components and their special spatial structure.30
To verify further the effect of the folate receptor on the 
intracellular uptake of FA-CS-SA, A549 cells were used as 
a negative control for the intracellular uptake experiment. 
Figure 6B showed that there was no significant difference 
between intracellular uptake of FA-CS-SA and that of 
CS-SA, regardless of the incubation time.
evaluation of cytotoxicity
The cytotoxicity of the FA-CS-SA and CS-SA copolymers 
were estimated by MTT assay. The IC50 value of CS-SA 
and FA-CS-SA were higher than that of Lipofectamine 
2000, suggesting that both CS-SA and FA-CS-SA had lower 
cytotoxicity compared with Lipofectamine 2000 regardless 
of the cell lines used, and the difference in cytotoxicity 
between FA-CS-SA and CS-SA was not significant. As 
Figure 7 shows, the IC50 values of the CS-SA and FA-CS-SA 
micelles against SKOV3 cells were 115.15 µg/mL and 
217.18 µg/mL, respectively, and against A549 cells were 
201.91 µg/mL and 298.46 µg/mL, while the IC50 values of 
Lipofectamine 2000 were about 9.91 µg/mL and 29.50 µg/
mL. The cytotoxicity of CS-SA and FA-CS-SA micelles 
at a higher concentration might originate from the large 
amounts of exogenous substances internalized into the cells. 
Thereafter, a lower concentration of micelles was used. The 
highest concentration used in gene delivery was 40 mg/mL 
when the N/P was 20, which was markedly lower than that 
of the IC50 value.
Transfection experiments
SKOV3 cells expressing folate receptors were used to 
determine whether gene delivery with FA-CS-SA is folate 
receptor-mediated. Transfection efficiencies of the FA-
CS-SA/DNA and CS-SA/DNA complexes at different N/P 
ratios varying from 1 to 20 were determined in our prelimi-
nary experiments. The maximum transfection efficiency of 
the FA-CS-SA/DNA complex was observed at an N/P ratio 
of 2, and this tended to decrease with further increases in the 
N/P ratio. The transfection efficiency of the copolymer/DNA 
complexes was visualized by fluorescence microscopy. The 
images in Figure 8 show that SKOV3 cells were transfected 
with copolymer/pEGFP-C1 complexes at optimal N/P ratios. 
The transfection efficiency of FA-CS-SA/DNA could not 
reach the high level of Lipofectamine 2000, but it was much 
higher than that of CS-SA/DNA.
To quantify transfection efficiency, the plasmid pGL-3 was 
used as the luciferase reporter gene, and a luciferase expres-
sion assay induced by the copolymers/pGL-3 complexes was 
carried out. Figure 9A shows the transfection efficiencies of 
FA-CS-SA/DNA, CS-SA/DNA, and Lipofectamine 2000/
DNA complexes at different N/P ratios in terms of luciferase 
activity of the protein expressed.   Figure 9B showed the 
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Figure 7 cytotoxicity of folic acid-conjugated stearic acid-grafted chitosan copolymer 
and  stearic  acid-grafted  chitosan  copolymer  in  comparison  with  LipofectamineTM 
2000 in (A) sKOV3 cells and (B) A549 cells.
Abbreviations: cs-sA, stearic acid-grafted chitosan copolymer; FA-cs-sA, folic 
acid-conjugated stearic acid-grafted chitosan copolymer.
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Figure 8 Green fluorescent protein detection of transfected SKOV3 cells observed 
by inverted microscopy.
Abbreviations: cs-sA, stearic acid-grafted chitosan copolymer; FA-cs-sA, folic 
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Figure  9  (A)  Transfection  efficiency  of  folic  acid-conjugated  stearic  acid-grafted  chitosan  copolymer/DNA  and  stearic  acid-grafted  chitosan  copolymer/DNA 
complexes  at  various  N/P  ratios  in  sKOV3  cells.  (B)  Transfection  efficiency  of  folic  acid-conjugated  stearic  acid-grafted  chitosan  copolymer  DNA  and  stearic 
acid-grafted  chitosan  copolymer/DNA  complexes  at  functional  N/P  ratios  in  sKOV3  cells.  (C)  Transfection  efficiency  of  folic  acid-conjugated  stearic  acid-
grafted  chitosan  copolymer/DNA  and  stearic  acid-grafted  chitosan  copolymer/DNA  complexes  at  various  N/P  ratios  in  A549  cells.  (D)  competitive  assay  of 
folic  acid-conjugated  stearic  acid-grafted  chitosan  copolymer/DNA  and  stearic  acid-grafted  chitosan  copolymer/DNA  complexes  by  adding  free  folic  acid  5.0  mM. 
Notes: Values are means ± standard deviation. *P , 0.05 and **P , 0.01.
Abbreviations: cs-sA, stearic acid-grafted chitosan copolymer; FA-cs-sA, folic acid-conjugated stearic acid-grafted chitosan copolymer.
transfection efficiencies of FA-CS-SA/DNA and CS-SA/
DNA complexes at optimal N/P ratios. It was found that the 
transfection efficiency of FA-CS-SA/DNA complexes was 
2.3-fold higher than that of the CS-SA/DNA complexes.
In order to demonstrate further the effect of the folate 
receptor on the transfection efficiencies of FA-CS-SA/DNA 
complexes, a transfection experiment was conducted using 
A549 cells deficient in the folate receptor. Figure 9C shows 
that the two complexes exhibited no difference in transfection 
efficiency in A549 cells, indicating that the folate ligand on 
FA-CS-SA plays a significant role in folate receptor recogni-
tion and enhanced transfection efficiency in SKOV3 cells.
From Figure 9D, it can be observed that, due to the com-
petitive displacement of free FA, the transfection efficiency of 
the FA-CS-SA/DNA complexes in SKOV3 cells was greatly 
reduced (by 5.4-fold) in the presence of excess FA (5.0 mM) 
compared with the medium free of FA, whereas the free FA 
in the medium did not affect the transfection efficiency of 
the CS-SA/DNA complexes. The results suggest that free FA 
molecules could prevent cellular uptake of the complexes by 
competitive binding to folate receptors on the cell surface. In 
other words, conjugation of FA indeed improved the trans-
fection efficiency of FA-CS-SA for gene delivery to folate 
receptor-positive cells.
Conclusion
FA-CS-SA was synthesized in this study by the reaction 
between the carboxyl groups of folate and the amine groups 
of CS-SA in the presence of EDC, which could self-aggregate 
to form micelle-like structures in aqueous solution. FA-CS-SA 
showed a good ability to form complexes with plasmid DNA 
and could efficiently protect condensed DNA from enzymatic 
degradation by DNase I. It had much lower cytotoxicity com-
pared with Lipofectamine 2000. Folate conjugation increased 
the intracellular uptake of FA-CS-SA in SKOV3 cells via 
folate receptor-mediated endocytosis at shorter incubation 
times. The FA-CS-SA/DNA complexes displayed higher 
transfection efficiency at certain N/P ratios in comparison with International Journal of Nanomedicine
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that of CS-SA/DNA complexes in SKOV3 cells, whereas no 
difference in folate receptor-negative A549 cells was found. 
The results suggest that FA-CS-SA has the potential to be a 
safe and effective nonviral vector for gene delivery.
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